Skip to main navigation Skip to search Skip to main content

Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndrome

  • Katrine Brække Norheim
  • , Juliana Imgenberg-Kreuz
  • , Andrei Alexsson
  • , Svein Joar Auglænd Johnsen
  • , Kjetil Bårdsen
  • , Johan Gorgas Brun
  • , Rezvan Kiani Dehkordi
  • , Elke Theander
  • , Thomas Mandl
  • , Roland Jonsson
  • , Wan Fai Ng
  • , Christopher J. Lessard
  • , Astrid Rasmussen
  • , Kathy Sivilis
  • , Lars Ronnblom
  • , Roald Omdal
  • Stavanger University Hospital
  • University of Bergen
  • Uppsala University
  • Lund University
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Newcastle University
  • Oklahoma Medical Research Foundation
  • Rheumatology Janssen Pharmaceutical Companies of Johnson and Johnson

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives Fatigue is common and severe in primary Sjögren's syndrome (pSS). The aim of this study was to identify genetic determinants of fatigue in pSS through a genome-wide association study. Methods Patients with pSS from Norway, Sweden, UK and USA with fatigue and genotype data available were included. After genotype imputation and quality control, 682 patients and 4 966 157 genetic markers were available. Association analysis in each cohort using linear regression with fatigue as a continuous variable and meta-Analyses between the cohorts were performed. Results Meta-Analysis of the Norwegian and Swedish cohorts identified five polymorphisms within the same linkage disequilibrium block at the receptor transporter protein 4 (RTP4)/MASP1 locus associated with fatigue with genome-wide significance (GWS) (p<5×10-8). Patients homozygous for the major allele scored 25 mm higher on the fatigue Visual Analogue Scale than patients homozygous for the minor allele. There were no variants associated with fatigue with GWS in meta-Analyses of the US/UK cohorts, or all four cohorts. RTP4 expression in pSS B cells was upregulated and positively correlated with the type I interferon score. Expression quantitative trait loci effects in whole blood for fatigue-Associated variants at RTP4/MASP1 and levels of RTP4 and MASP1 expression were identified. Conclusion Genetic variations at RTP4/MASP1 are associated with fatigue in Scandinavian pSS patients. RTP4 encodes a Golgi chaperone that influences opioid pain receptor function and MASP1 is involved in complement activation. These results add evidence for genetic influence over fatigue in pSS.

Original languageEnglish
Article numbere001832
JournalRMD Open
Volume7
Issue number3
DOIs
Publication statusPublished - 1 Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • autoimmune diseases
  • genetic
  • polymorphism
  • sjogren's syndrome

Fingerprint

Dive into the research topics of 'Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndrome'. Together they form a unique fingerprint.

Cite this